Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aerosol inhalation of amphotericin B for prevention of pulmonary fungal infection in high-risk hematology patients
ChiCTR2000040882Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of amphotericin b in fungal pneumonia and invasive mycoses (2 arms), sponsored by First Affiliated Hospital of Soochow University. Primary endpoint: Incidence of fungal infection. Started Dec 2020; status: recruiting.
02
Drugs
amphotericin b
03
Conditions
fungal pneumoniainvasive mycoses
Beyond the preview
Go deeper on ChiCTR2000040882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000040882.